{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:40:59Z","timestamp":1772142059727,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.msard.2024.105666","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T07:49:26Z","timestamp":1715154566000},"page":"105666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Whole spinal transverse myelitis in neuromyelitis optica spectrum disorder"],"prefix":"10.1016","volume":"87","author":[{"given":"Masoud","family":"Etemadifar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soulmaz","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehri","family":"Salari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Ali","family":"Hosseinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3146-2438","authenticated-orcid":false,"given":"Amir Reza","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.msard.2024.105666_bib0007","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/00207454.2020.1860036","article-title":"Covid-19 infection-induced neuromyelitis optica: a case report","volume":"132","author":"Batum","year":"2022","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.msard.2024.105666_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104611","article-title":"Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin America","volume":"72","author":"Carnero Contentti","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"14","key":"10.1016\/j.msard.2024.105666_bib0014","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1177\/1352458518815596","article-title":"Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity","volume":"25","author":"Chien","year":"2019","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"3","key":"10.1016\/j.msard.2024.105666_bib0018","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2024.105666_bib0004","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-323-98817-9.00020-X","article-title":"Transverse myelitis in children and adults","volume":"196","author":"Grasso","year":"2023","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105666_bib0016","first-page":"98","article-title":"Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: an Iranian Experience","volume":"14","author":"Harirchian","year":"2015","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.msard.2024.105666_bib0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflammation."},{"issue":"4","key":"10.1016\/j.msard.2024.105666_bib0015","first-page":"204","article-title":"A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province","volume":"14","author":"Kashipazha","year":"2015","journal-title":"Iran. Iran J Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105666_bib0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1352458511406165","article-title":"The differential diagnosis of longitudinally extensive transverse myelitis","volume":"18","author":"Kitley","year":"2012","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"9451","key":"10.1016\/j.msard.2024.105666_bib0002","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet Lond. Engl."},{"issue":"4","key":"10.1016\/j.msard.2024.105666_bib0012","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neuroscience.2004.08.053","article-title":"Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1","volume":"129","author":"Nagelhus","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.msard.2024.105666_bib0001","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/460825","article-title":"Neuromyelitis optica: an antibody-mediated disorder of the central nervous system","volume":"2012","author":"Oh","year":"2012","journal-title":"Neurol. Res. Int."},{"issue":"6","key":"10.1016\/j.msard.2024.105666_bib0011","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105666_bib0003","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide Incidence and Prevalence of Neuromyelitis Optica: a Systematic Review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.msard.2024.105666_bib0006","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1352458515591069","article-title":"Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging","volume":"22","author":"Pekcevik","year":"2016","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"key":"10.1016\/j.msard.2024.105666_bib0008","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2377-9-56","article-title":"Patient with neuromyelitis optica and inflammatory demyelinating lesions comprising whole spinal cord from C2 level till conus: case report","volume":"9","author":"Petelin Gadze","year":"2009","journal-title":"BMC. Neurol."},{"key":"10.1016\/j.msard.2024.105666_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103011","article-title":"Conus involvement and leptomeningeal enhancement in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a case report","volume":"52","author":"Safadi","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2024.105666_bib0019","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2214\/AJR.20.24061","article-title":"MOGAD: how It Differs From and Resembles Other Neuroinflammatory Disorders","volume":"216","author":"Shahriari","year":"2021","journal-title":"AJR Am. J. Roentgenol."},{"issue":"3","key":"10.1016\/j.msard.2024.105666_bib0017","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105666_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T12:06:30Z","timestamp":1720872390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824002438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":20,"alternative-id":["S2211034824002438"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105666","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole spinal transverse myelitis in neuromyelitis optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105666"}}